In a deal worth up to $380 million in upfront and milestone payments, Bristol Myers Squibb and Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing...
Light Pharma Inc, a biotechnology company creating designated and extraordinary cancer treatments utilizing its restrictive RADR® artificial intelligence and AI ("ML") stage with various clinical-stage drug programs, reported today that the...
The pharmaceutical company Eli Lilly announced in a new tab that it will acquire Nexus Pharmaceuticals' manufacturing facility to produce injectable medicines. The firm expects creation at the office situated in Charming Grassland, Wisconsin...
Zydus Lifesciences, an India-based pharmaceutical company, announced the availability of a generic treatment for overactive bladder in the US market. Zydus stated in a regulatory filing that the company has launched Mirabegron extended-release...
The Atal Incubation Centre - Centre for Cellular and Molecular Biology (AIC-CCMB), a premier bio-incubator in Hyderabad, has signed an agreement with Thermo Fisher Scientific.
Mac-Chem Products (India) Pvt. Ltd. (Mac-Chem) announced today the successful renewal of its European Union Goods Manufacturing Practices) (EU-GMP certification for its manufacturing facility in Boisar.
The Indian Institute of Science (IISc) announces the launch of the Longevity India Initiative, a project focused on efforts to extend human 'healthspan' and tackle ageing-related challenges
Takeda, a leading pharmaceutical firm, declared that the US Food and Drug Administration (FDA) has granted approval for the subcutaneous administration of Entyvio (vedolizumab) as maintenance therapy in adults with moderately to severely active...
Evotec SE and Variant Bio, Inc. have agreed to work together to find the best treatment for fibrosis-related diseases. In organs like the liver and lungs, fibrosis is characterized by a marked and pathogenic accumulation of the tissue matrix and...
Healthcare requires customized financing, expertise, and collaborations says Ajay Banga, World Bank President. He stated that while and after COVID, money for healthcare rose; but, in order to make healthcare inexpensive and accessible to all...